# SYNAPSE Phase 2 × Synthea: Implementation & Acceptance Verification Report

**Status:** ALL PHASES IMPLEMENTED & TESTED  
**Date:** 2026-10-21  
**Test Suite:** 134 Passed (0 Failed, 0 Skipped, 0 Warnings) — Baseline was 105  
**Artifacts Generated:** 12 Compatible Simplified CSVs + 4 Additive Longitudinal CSVs  

---

## 1. Executive Implementation Summary

In accordance with the architectural decisions approved in [ADR-001](file:///Users/shashi/synapse/synapse-phase2/docs/research_alignment/ADR.md) and the methodological principles of Synthea (*Walonoski et al., JAMIA 2018, PMC7651916*), the SYNAPSE Phase 2 simulation platform has been successfully evolved into a longitudinal, research-aligned synthetic healthcare data generator.

Key architectural goals achieved:
1. **Deterministic Reproducibility (G0):** All `uuid4` call sites replaced with a seeded, bijective `IdFactory`. Two identical seeds produce 100% byte-identical SHA-256 hashes across all 16 CSV artifacts.
2. **Population Profile Architecture (G1):** Pydantic-validated population profile system (`PopulationProfile`, `DemographicsConfig`, `ConditionPrevalenceConfig`, `MortalityConfig`) backed by an empirical `provenance_catalog` with Census of India SRS 2021 demographics, ICMR-INDIAB 2023 disease prevalences, and SRS life tables. Cross-geographic statistical borrowing without explicit assumption flags is strictly blocked.
3. **Clinical Module Framework (G2 & G3):** Full generic module engine (`ClinicalModuleRunner`) implementing the 7 Synthea control states (`Initial`, `Terminal`, `Simple`, `Guard`, `Delay`, `SetAttribute`, `Counter`), 11 clinical states (`Encounter`, `ConditionOnset`, `ConditionEnd`, `MedicationOrder`, `MedicationEnd`, `CarePlanStart`, `CarePlanEnd`, `Procedure`, `Observation`, `Symptom`, `Death`), and 4 transition types (`Direct`, `Distributed`, `Conditional`, `Complex`).
4. **Biological Onset vs. Clinical Diagnosis (G4):** Latent condition onset occurs biologically in patient internal state and is never backdated into the clinical record before its valid clinical recognition encounter.
5. **Terminal Death & Action Invalidation (G5):** Death acts as a terminal event; patient status transitions to `Deceased`, and all future actions are purged from the scheduler. The simulation engine defensively drops stale actions targeting deceased patients.
6. **Clinical Safety Supremacy (G6 & G7):** Modules probabilistically propose actions, but the Level 80 Clinical Safety rules (e.g. `RULE-CLIN-ALLERGY-001`) in `RuleEngine` maintain unconditional veto authority over contraindicated prescriptions.
7. **Longitudinal Exporters (G10):** Refactored `CSVExporter` removes single-encounter and single-condition constraints while maintaining 100% header and schema compatibility with the original 12 simplified CSVs and outputting 4 additive longitudinal tables (`patient_timeline.csv`, `observations.csv`, `care_plans.csv`, `deaths.csv`).
8. **Three-Tiered Population Validator (G8):** Implemented structural blocking, plausibility auditing, and statistical realism checking with 95% Wilson confidence intervals, Jensen-Shannon divergence, and strict separation between `VERIFIED` and `UNVERIFIED_ESTIMATE` metrics.

---

## 2. Verification of the 14 Acceptance Criteria

| # | Acceptance Criterion | Verification Method | Status |
|---|---|---|:---:|
| 1 | **Deterministic Reproducibility** | Executed dual cohort generations with identical seed (`seed=101`). Computed SHA-256 digests across all 16 exported CSV artifacts. Digests matched byte-for-byte. | **PASSED** |
| 2 | **Stochastic Divergence** | Compared cohorts generated with `seed=101` vs `seed=202`. Verified patient rosters, demographics, and event sequences differed. | **PASSED** |
| 3 | **Population Distribution Fidelity** | Tested in `test_population_profile.py` and `test_end_to_end_acceptance.py`. Sampled sex ratio ($0.515 \pm 0.03$) and age marginals match reference distributions. | **PASSED** |
| 4 | **Longitudinal Encounters & Timelines** | Validated in `test_longitudinal_multi_encounter_and_additive_export` and end-to-end multi-year runs. Patients accumulate $>1$ encounter over time. | **PASSED** |
| 5 | **Temporal Constraint Integrity** | Tested in `test_end_to_end_14_acceptance_criteria`. Invariant: $\text{birth} \le \text{onset} \le \text{encounter} \le \text{death} \le \text{window\_end}$ holds across 100% of records. | **PASSED** |
| 6 | **No Retroactive Diagnoses** | Validated in `test_latent_condition_onset_precedes_encounter_diagnosis`. Latent onset precedes diagnosis, and diagnosis timestamp equals encounter time. | **PASSED** |
| 7 | **Terminal Death Invalidation** | Validated in `test_death_state_halts_modules_and_marks_deceased`. Scheduler invalidates pending actions, and engine drops post-mortem actions. | **PASSED** |
| 8 | **Clinical Safety Rule Enforcement** | Validated in `test_allergy_safety_veto_on_module_amoxicillin`. Rule `RULE-CLIN-ALLERGY-001` intercepts module-proposed Amoxicillin in Penicillin allergy with status `BLOCKED`. | **PASSED** |
| 9 | **Legacy Operational Compatibility** | Full regression suite of existing operational scenarios (`SCEN-V1-01` through `SCEN-V1-04`, pharmacy stock, finance billing) ran and passed with zero regressions. | **PASSED** |
| 10 | **CSV Schema Backward Compatibility** | Validated in `test_headers_backward_compatibility`. All 12 simplified CSV headers match the baseline committed headers recorded at repository start. | **PASSED** |
| 11 | **Structural Validation Gate Authority** | Validated in `test_tier1_structural_blocks_on_dangling_fk`. Tier 1 failures return `status="BLOCK"` and `blocks_publication=True`. | **PASSED** |
| 12 | **Statistical Verification Labelling** | Validated in `test_tier3_statistical_distinguishes_verified_from_unverified`. Metrics with cited provenance (SRS, ICMR-INDIAB) are labeled `VERIFIED`; uncited or assumption metrics are labeled `UNVERIFIED_ESTIMATE`. | **PASSED** |
| 13 | **Comprehensive Test Suite Coverage** | Regression suite expanded from 105 tests to 134 tests (29 new tests across 6 dedicated test modules). All 134 tests executed and passing. | **PASSED** |
| 14 | **Performance Benchmark** | Full multi-year longitudinal simulation of a 30-patient cohort completed in $<1.0\text{s}$, well within the $<60.0\text{s}$ threshold. | **PASSED** |

---

## 3. Test Suite Progression

| Test File | Test Count | Description / Coverage |
|---|:---:|---|
| `tests/test_determinism.py` | 10 | Seeded `IdFactory` uniqueness, bijection, cross-process determinism under varied `PYTHONHASHSEED`. |
| `tests/test_population_profile.py` | 5 | YAML population profile parsing, missing provenance errors, geographic isolation, `PopulationSampler`. |
| `tests/test_clinical_modules.py` | 6 | State machine models, evaluator, latent onset vs diagnosis, death halting, allergy safety veto. |
| `tests/test_longitudinal_export.py` | 2 | Header backward compatibility with baseline, multi-encounter export, 4 additive longitudinal tables. |
| `tests/test_population_validator.py` | 5 | Wilson score confidence interval, Jensen-Shannon divergence, Tier 1/2/3 validation mechanics. |
| `tests/test_end_to_end_acceptance.py` | 1 | End-to-end multi-year longitudinal simulation exercising all 14 acceptance criteria simultaneously. |
| **Legacy SYNAPSE Test Suite** | **105** | Core simulation engine, operational workflows, pharmacy stock, billing, radiology, lab, PubMed integration. |
| **TOTAL** | **134** | **100% Pass Rate** |

---

## 4. Modified and New Source Files

### New Modules & Configurations
- `synapse_simulator/core/ids.py`: Bijective seeded ID generator replacing `uuid4`.
- `synapse_simulator/population/models.py`: Pydantic models for population profiles, demographics, prevalence, and mortality.
- `synapse_simulator/population/loader.py`: Profile loader and `PopulationSampler`.
- `synapse_simulator/modules/models.py`: Pydantic models for 7 control states, 11 clinical states, and 4 transition types.
- `synapse_simulator/modules/evaluator.py`: Safe expression evaluation (`SimpleEval`) against patient attributes and history.
- `synapse_simulator/modules/engine.py`: `ClinicalModuleRunner` executing longitudinal module transitions.
- `synapse_simulator/modules/loader.py`: Module YAML loader.
- `synapse_simulator/validation/population_validator.py`: Three-tiered validator (structural, plausibility, statistical).
- `config/population/india_default_v1.yaml`: Indian baseline profile (SRS 2021 demographics, ICMR-INDIAB 2023, SRS life tables).
- `config/modules/hypertension.yaml`: Essential Hypertension (`I10`) clinical module.
- `config/modules/diabetes_t2.yaml`: Type 2 Diabetes Mellitus (`E11.9`) clinical module.
- `config/modules/urti.yaml`: Acute Upper Respiratory Infection (`J06.9`) clinical module.

### Modified Files (Preserving Existing Architecture)
- `synapse_simulator/datagen/models.py`: Added longitudinal fields (`birth_date`, `death_date`, `is_alive`, `attributes`, `latent_conditions`) to `PatientContext`.
- `synapse_simulator/datagen/patient_generator.py`: Integrated `PopulationSampler` for age, sex, and baseline chronic conditions.
- `synapse_simulator/state/models.py`: Added `PatientStatus.DECEASED` and `extra_context` to `ActionRequest`.
- `synapse_simulator/transitions/state_machine.py`: Added `Deceased` as terminal state in `PatientStateMachine`.
- `synapse_simulator/core/simulation_engine.py`: Added pre-execution deceased patient guards and invalidation triggers.
- `synapse_simulator/state/state_manager.py`: Merged action `extra_context` into `InputContext`.
- `synapse_simulator/exporter/csv_exporter.py`: Removed 1-encounter and 1-condition constraints; added 4 additive tables (`patient_timeline.csv`, `observations.csv`, `care_plans.csv`, `deaths.csv`).
- `config/rules/departments/pharmacy.yaml`: Generalized allergy rule `RULE-CLIN-ALLERGY-001` to all scenarios (`["SCEN-V1-03", "*"]`).

---

## 5. Known Limitations & Sourced Evidence Boundary

1. **Adherence Modeling:** Similar to Synthea, medication adherence is currently modeled as full adherence once dispensed; partial adherence and discontinuation dynamics can be refined in subsequent modules.
2. **Mortality Calibration:** Natural background mortality is sourced from the Registrar General of India SRS Abridged Life Tables (2016–2020). Excess disease mortality is modeled inside specific chronic pathways.
3. **Pluggable Geographies:** The system enforces strict provenance: any new geographic profile (e.g. US, UK, Brazil) must provide cited local reference distributions. Cross-geographic borrowing is strictly forbidden unless explicitly tagged as an assumption.
